| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-actinin binding | 5.78e-04 | 31 | 23 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | actinin binding | 1.11e-03 | 43 | 23 | 2 | GO:0042805 | |
| Domain | ADAM_spacer1 | 3.30e-04 | 23 | 22 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 3.30e-04 | 23 | 22 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.60e-04 | 24 | 22 | 2 | IPR013273 | |
| Domain | Peptidase_M12B_N | 9.56e-04 | 39 | 22 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 9.56e-04 | 39 | 22 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.01e-03 | 40 | 22 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 1.01e-03 | 40 | 22 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.01e-03 | 40 | 22 | 2 | PS50214 | |
| Domain | Reprolysin | 1.01e-03 | 40 | 22 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 1.01e-03 | 40 | 22 | 2 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 1.06e-03 | 41 | 22 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 1.06e-03 | 41 | 22 | 2 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 1.16e-03 | 43 | 22 | 2 | IPR001818 | |
| Domain | Znf_C2H2 | 2.10e-03 | 805 | 22 | 5 | IPR007087 | |
| Domain | TSP_1 | 2.48e-03 | 63 | 22 | 2 | PF00090 | |
| Domain | TSP1 | 2.63e-03 | 65 | 22 | 2 | SM00209 | |
| Domain | TSP1_rpt | 2.63e-03 | 65 | 22 | 2 | IPR000884 | |
| Domain | TSP1 | 2.63e-03 | 65 | 22 | 2 | PS50092 | |
| Domain | MetalloPept_cat_dom | 4.06e-03 | 81 | 22 | 2 | IPR024079 | |
| Domain | - | 4.06e-03 | 81 | 22 | 2 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 5.88e-03 | 98 | 22 | 2 | PS00142 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.18e-02 | 775 | 22 | 4 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.20e-02 | 777 | 22 | 4 | PS00028 | |
| Domain | Znf_C2H2-like | 1.30e-02 | 796 | 22 | 4 | IPR015880 | |
| Domain | ZnF_C2H2 | 1.36e-02 | 808 | 22 | 4 | SM00355 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.87e-06 | 608 | 24 | 6 | 36089195 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.69e-06 | 351 | 24 | 5 | 38297188 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 3.00e-05 | 12 | 24 | 2 | 25770910 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.42e-05 | 588 | 24 | 5 | 38580884 | |
| Pubmed | Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. | 7.75e-05 | 19 | 24 | 2 | 20395239 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.27e-04 | 736 | 24 | 5 | 29676528 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.33e-04 | 1203 | 24 | 6 | 29180619 | |
| Pubmed | 1.36e-04 | 25 | 24 | 2 | 29475039 | ||
| Pubmed | 1.81e-04 | 418 | 24 | 4 | 34709266 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.98e-04 | 1294 | 24 | 6 | 30804502 | |
| Pubmed | 2.59e-04 | 181 | 24 | 3 | 37372979 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 2.88e-04 | 877 | 24 | 5 | 20211142 | |
| Pubmed | 3.39e-04 | 1429 | 24 | 6 | 35140242 | ||
| Pubmed | 3.42e-04 | 199 | 24 | 3 | 23382691 | ||
| Pubmed | 4.24e-04 | 44 | 24 | 2 | 20200978 | ||
| Pubmed | 4.24e-04 | 44 | 24 | 2 | 25010285 | ||
| Pubmed | 4.70e-04 | 222 | 24 | 3 | 37071664 | ||
| Pubmed | 6.39e-04 | 54 | 24 | 2 | 22266860 | ||
| Interaction | CBX3 interactions | 5.27e-06 | 646 | 23 | 7 | int:CBX3 | |
| Interaction | H3C3 interactions | 1.51e-05 | 495 | 23 | 6 | int:H3C3 | |
| Interaction | H2BC8 interactions | 3.54e-05 | 576 | 23 | 6 | int:H2BC8 | |
| Cytoband | 14q21.2 | 4.95e-05 | 20 | 24 | 2 | 14q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q21 | 1.18e-03 | 97 | 24 | 2 | chr14q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q21 | 1.74e-03 | 118 | 24 | 2 | chr10q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | 1.66e-02 | 378 | 24 | 2 | chr6p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 2.04e-02 | 422 | 24 | 2 | chr20q13 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.09e-04 | 19 | 15 | 2 | 50 | |
| GeneFamily | PHD finger proteins | 2.47e-03 | 90 | 15 | 2 | 88 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ALMS1 FANCM CPLANE1 ATAD5 IARS1 ZNF644 MIS18BP1 BCAS1 ZNF184 CNTLN | 2.76e-07 | 1252 | 23 | 10 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ALMS1 FANCM CPLANE1 UHRF2 ATAD5 ZNF644 MIS18BP1 ZNF184 CNTLN | 3.33e-06 | 1257 | 23 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 8.73e-06 | 1414 | 23 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 1.08e-05 | 492 | 23 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ALMS1 FANCM CPLANE1 UHRF2 ATAD5 ZNF644 MIS18BP1 ZNF184 CNTLN | 1.13e-05 | 1459 | 23 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 1.18e-05 | 1468 | 23 | 9 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.91e-05 | 316 | 23 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 2.96e-05 | 1241 | 23 | 8 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 5.55e-05 | 69 | 23 | 3 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 5.80e-05 | 986 | 23 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 9.17e-05 | 1060 | 23 | 7 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 1.14e-04 | 749 | 23 | 6 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.25e-04 | 469 | 23 | 5 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 1.68e-04 | 804 | 23 | 6 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 2.05e-04 | 107 | 23 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.94e-04 | 121 | 23 | 3 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.70e-04 | 323 | 23 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.48e-04 | 29 | 23 | 2 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 4.49e-04 | 1370 | 23 | 7 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 4.55e-04 | 967 | 23 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#2_top-relative-expression-ranked_500 | 4.79e-04 | 30 | 23 | 2 | gudmap_developingGonad_e14.5_ ovary_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 4.83e-04 | 978 | 23 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | 5.02e-04 | 985 | 23 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | 5.13e-04 | 989 | 23 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.24e-04 | 993 | 23 | 6 | ratio_EB-blastocyst_vs_EB-fibro_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 5.41e-04 | 149 | 23 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.50e-04 | 375 | 23 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.56e-04 | 376 | 23 | 4 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.41e-04 | 166 | 23 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.07e-04 | 178 | 23 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 9.66e-04 | 417 | 23 | 4 | GSM399403_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.01e-03 | 185 | 23 | 3 | ratio_EB-blastocyst_vs_EB-fibro_1000_K5 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 1.02e-03 | 423 | 23 | 4 | GSM791126_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 1.08e-03 | 45 | 23 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#4_top-relative-expression-ranked_500 | 1.13e-03 | 46 | 23 | 2 | gudmap_developingGonad_e12.5_epididymis_k4_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | 1.21e-03 | 1164 | 23 | 6 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.35e-03 | 790 | 23 | 5 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.44e-03 | 801 | 23 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.56e-03 | 815 | 23 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | 1.62e-03 | 822 | 23 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.70e-03 | 831 | 23 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.92e-08 | 196 | 24 | 5 | 85684b881655e47f06f0cf00721183825fa00913 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-06 | 196 | 24 | 4 | e38036a5dbaed1488e01616bdc7678b28968470b | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.68e-06 | 199 | 24 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.79e-05 | 95 | 24 | 3 | 56350551af6a1ae15652d596002124d8f7885d4f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.85e-05 | 149 | 24 | 3 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.98e-05 | 150 | 24 | 3 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.99e-05 | 157 | 24 | 3 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-05 | 167 | 24 | 3 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.77e-05 | 168 | 24 | 3 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 1.05e-04 | 172 | 24 | 3 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 178 | 24 | 3 | 8b939659f713eea50a1a6e28b571f680ca0b4c12 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.18e-04 | 179 | 24 | 3 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.32e-04 | 186 | 24 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.41e-04 | 190 | 24 | 3 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-04 | 190 | 24 | 3 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-04 | 192 | 24 | 3 | f518839ecd9377537a414e8798766f7d91eafeac | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-04 | 193 | 24 | 3 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.47e-04 | 193 | 24 | 3 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-04 | 193 | 24 | 3 | 9f798a1bbd9f076c3122d02ed28418c18bb7a369 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.47e-04 | 193 | 24 | 3 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.47e-04 | 193 | 24 | 3 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 1.49e-04 | 194 | 24 | 3 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.49e-04 | 194 | 24 | 3 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 195 | 24 | 3 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | COVID-19-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 1.52e-04 | 195 | 24 | 3 | 9ad844d9d5aac39d133ae8ab9c4839300f08064c | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 195 | 24 | 3 | 8b2e29f3b12fcc474abdf3707de96e4613ead1bc | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 196 | 24 | 3 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 197 | 24 | 3 | 1ca06d6d288cb58a6e8062ebc01831e58ee5be4b | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-04 | 198 | 24 | 3 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 198 | 24 | 3 | 6b8baa0b76242736f6dba482cdaad019256877ea | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-04 | 198 | 24 | 3 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-04 | 198 | 24 | 3 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 198 | 24 | 3 | 8519c7bd5f6c5a97f5e43f4729b1411d3b07e4c8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 198 | 24 | 3 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 1.61e-04 | 199 | 24 | 3 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.61e-04 | 199 | 24 | 3 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 1.63e-04 | 200 | 24 | 3 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-04 | 200 | 24 | 3 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.63e-04 | 200 | 24 | 3 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 1.63e-04 | 200 | 24 | 3 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 1ec2f322f936d2501330c53bb7c9390216c50cd1 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.63e-04 | 200 | 24 | 3 | abcbd5a156aa4fd51d284441388975c81c0b88ae | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD--L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | e250b2e45ef869f81cc40cc41f53d1e54e7848aa | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-04 | 200 | 24 | 3 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.63e-04 | 200 | 24 | 3 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.63e-04 | 200 | 24 | 3 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 200 | 24 | 3 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 30dc7ffef2052ee8610cdca952ca12f240bcec50 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 200 | 24 | 3 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | dea96adbd9a77fe50ff397d4bdeb4dc8f50de3b7 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 200 | 24 | 3 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 200 | 24 | 3 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 200 | 24 | 3 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.58e-04 | 59 | 24 | 2 | 2d77ae08fa9836bbae158a0e466806a5f9236b5e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.58e-04 | 59 | 24 | 2 | d49a63218a045f3d032d135aee234a3269222abd | |
| ToppCell | VE-CD8-proli_CD4|VE / Condition, Cell_class and T cell subcluster | 1.33e-03 | 101 | 24 | 2 | 5293f15b5ed340e6d0282b56de13752eabeef8dd | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.97e-03 | 123 | 24 | 2 | de29861800d083e4977afbef59c1a81336824703 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-03 | 127 | 24 | 2 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-03 | 129 | 24 | 2 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-03 | 130 | 24 | 2 | 0f9d3e6297f48ae14d24ac997d8d3a94f337d4d4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.19e-03 | 130 | 24 | 2 | fc68a648161dd314d9ee6612fd039cb12171b8c6 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.29e-03 | 133 | 24 | 2 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-03 | 134 | 24 | 2 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-03 | 135 | 24 | 2 | 0e5dfbe79598fc7822a7b3baa8d7dba3c9da1dad | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 2.50e-03 | 139 | 24 | 2 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.50e-03 | 139 | 24 | 2 | 9e2a84d5ed7232b70eadbba754d9ca13f2d50fe9 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-intermediate_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.61e-03 | 142 | 24 | 2 | 9b39c778cfaf457303010f1b1cae8c0cd8fe5d1d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.72e-03 | 145 | 24 | 2 | 734d85ca7a2e5e040f433cadc5f9be1f25cf2e91 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-03 | 145 | 24 | 2 | 8ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 2.79e-03 | 147 | 24 | 2 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-9|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.83e-03 | 148 | 24 | 2 | 683b2b80ee389469d948aaf6a77632b24f56e989 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-03 | 149 | 24 | 2 | 13b445c13bb8f31ff0876addd1baf969ae220ea3 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 2.94e-03 | 151 | 24 | 2 | 9bfb807e1180b31fa9a2c500ce993de9707c070f | |
| ToppCell | severe_COVID-19-Treg|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.94e-03 | 151 | 24 | 2 | bef8f31d5c4345a346fcf15db0fa36265ac304e7 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-03 | 151 | 24 | 2 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-03 | 151 | 24 | 2 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-03 | 152 | 24 | 2 | f717aae4882e9b67e5e40f4ef5b0d35f74a89165 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.98e-03 | 152 | 24 | 2 | 072daae0deb6cb92f126e4566f1d264cda9ed157 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-03 | 153 | 24 | 2 | cda759ab83a271974651fe4faa21ed4f7ecbb3ae | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.02e-03 | 153 | 24 | 2 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | IIH-Treg|IIH / Condition, Cell_class and T cell subcluster | 3.02e-03 | 153 | 24 | 2 | 17704e18833812fcf2a2727b1e3f8a9984ba5b59 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.06e-03 | 154 | 24 | 2 | e16f200391537aa1002b0079481b94e1fb86b9ad | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 3.06e-03 | 154 | 24 | 2 | 5ff380205fa7ab97ba21f6512bc9e14c0fb320b6 | |
| ToppCell | IIH-Treg-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 3.06e-03 | 154 | 24 | 2 | d2211a892654b92decb208969040920f7ae8ba1e | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.10e-03 | 155 | 24 | 2 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-03 | 155 | 24 | 2 | 0fd66c623cb433ceaa893bc21ba2e3b394faaf70 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-03 | 157 | 24 | 2 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | Healthy/Control-Treg|Healthy/Control / Disease group and Cell class | 3.25e-03 | 159 | 24 | 2 | 16a322760c99f3e2c3b73cbb399f77868951d3cb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-03 | 159 | 24 | 2 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-03 | 159 | 24 | 2 | 235ed12053b337aca5abc2ce8727332b4ae3f8ae | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.25e-03 | 159 | 24 | 2 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-03 | 159 | 24 | 2 | 08a1cd71eac4322fb313324f74fe8e37998f2d7d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.25e-03 | 159 | 24 | 2 | 9bdfa7f5aa7753fe25b787bd43d694b6093d77eb | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.29e-03 | 160 | 24 | 2 | 6b5b5aa12f0d00757728f5597f569d68406d6f56 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.29e-03 | 160 | 24 | 2 | c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-03 | 161 | 24 | 2 | 5cb91ae9674b370a27be0d5852c3816b4434239e | |
| Disease | serum IgG glycosylation measurement | 5.52e-05 | 523 | 24 | 5 | EFO_0005193 | |
| Disease | forced expiratory volume | 3.76e-04 | 789 | 24 | 5 | EFO_0004314 | |
| Disease | serum metabolite measurement | 8.53e-04 | 945 | 24 | 5 | EFO_0005653 | |
| Disease | creatinine measurement | 1.08e-03 | 995 | 24 | 5 | EFO_0004518 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 1.20e-03 | 63 | 24 | 2 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | coffee consumption measurement, major depressive disorder | 1.24e-03 | 64 | 24 | 2 | EFO_0006781, MONDO_0002009 | |
| Disease | vital capacity | 2.79e-03 | 1236 | 24 | 5 | EFO_0004312 | |
| Disease | risk-taking behaviour | 3.14e-03 | 764 | 24 | 4 | EFO_0008579 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.29e-03 | 105 | 24 | 2 | DOID:9352 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KHPEKNQKKLQCLND | 761 | Q96QE3 | |
| HDKNAKKPTFQKKNC | 936 | Q9NXG0 | |
| EKHEKGAQKTDCQKN | 151 | Q7L266 | |
| QDCVVEKNNQHKPKS | 2991 | Q8TCU4 | |
| CKNKKEEQRAHQKDP | 351 | Q3KP44 | |
| PKLNENKNIHQAKEC | 91 | Q8N7U9 | |
| NKNIHQAKECEKSPF | 96 | Q8N7U9 | |
| DQQCQAHDRLSPKKK | 606 | Q8TE56 | |
| KQKIQCQQEKKAPLH | 201 | Q6P0N0 | |
| NPSTVKKNKQQDHCL | 1691 | Q8IYD8 | |
| KKNKQQDHCLNSVPS | 1696 | Q8IYD8 | |
| HQRQSACNLEKKQKK | 1431 | P35579 | |
| CRQAPHLKAAQKNKQ | 836 | Q9BZA7 | |
| DNNKCKEEGVKSPQH | 446 | Q9P2N4 | |
| HKPTDKRKMCNQKEN | 1506 | Q9H799 | |
| ENKKQVSKNCRKHEE | 156 | Q8IYT3 | |
| KQKSNKQEAKEPAQC | 511 | O75363 | |
| NCFQECLKQSKHKPK | 26 | P41252 | |
| LTKPKNNHNCKKVSN | 291 | Q14865 | |
| NNHNCKKVSNEEKPK | 296 | Q14865 | |
| CKRTNGNIKHKSKEN | 171 | Q96PU4 | |
| NNTLVDPCEEHKKKN | 691 | P23497 | |
| VHKPKDCQTSFQKNN | 56 | Q9H582 | |
| KNEVKEKGHVNCPND | 741 | Q96KM6 | |
| QNSNPVKKEKSCKCN | 211 | Q99676 | |
| KNLNPNSKHSQCNKV | 226 | Q5JNZ3 | |
| RACKNHKSKLESQNK | 176 | Q86TC9 |